Explore Jobs
Find Specific Jobs
Explore Careers
Explore Professions
Best Companies
Explore Companies
Halozyme revenue
Halozyme's revenue is $1.0 billion.
What is Halozyme's revenue?
- Halozyme's revenue growth from 2005 to 2022 is 518,822.4%.
- Halozyme has 136 employees, and the revenue per employee ratio is $4,853,794.
- Halozyme's peak quarterly revenue was $221.0M in 2023(q2).
- Halozyme peak revenue was $660.1M in 2022.
- Halozyme annual revenue for 2021 was 443.3M, 65.67% growth from 2020.
- Halozyme annual revenue for 2022 was 660.1M, 48.91% growth from 2021.
On This Page
Advance your career for $10/month
Halozyme historical revenue
Halozyme's peak revenue was $660.1M in 2022. The peak quarterly revenue was $221.0M in 2023(q2).
Halozyme's revenue increased from $127.2k in 2005 to $660.1M currently. That's a 518,822.4% change in annual revenue.
Halozyme annual revenue
Halozyme annual revenue over time
| Fiscal Year / Year | Halozyme Revenue |
|---|---|
| 2009 | $13.7M |
| 2010 | $13.6M |
| 2011 | $56.1M |
| 2012 | $42.3M |
| 2013 | $54.8M |
| 2014 | $75.3M |
| 2015 | $135.1M |
| 2016 | $146.7M |
| 2017 | $316.6M |
| 2018 | $151.9M |
| 2019 | $196.0M |
| 2020 | $267.6M |
| 2021 | $443.3M |
| 2022 | $660.1M |
| 2023 | $829.3M |
| 2024 | $1.0B |
Rate Halozyme's financial transparency
Halozyme annual growth
Halozyme saw the greatest revenue growth in 2006, when revenue increased by 671.76%.
Halozyme had the lowest revenue growth in 2018, when revenue changed by -52.04%.
Halozyme annual growth rate over time
| Year | Halozyme Growth |
|---|---|
| 2009 | 56%↑ |
| 2010 | -0%↓ |
| 2011 | 312%↑ |
| 2012 | -25%↓ |
| 2013 | 29%↑ |
| 2014 | 37%↑ |
| 2015 | 79%↑ |
| 2016 | 9%↑ |
| 2017 | 116%↑ |
| 2018 | -52%↓ |
| 2019 | 29%↑ |
| 2020 | 37%↑ |
| 2021 | 66%↑ |
| 2022 | 49%↑ |
| 2023 | 26%↑ |
| 2024 | 22%↑ |
Halozyme quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Halozyme quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2009 | $2.8M | $1.4M | $3.0M | $6.4M |
| 2010 | $3.4M | $3.2M | $3.4M | $3.6M |
| 2011 | $7.5M | $23.2M | $22.9M | $2.4M |
| 2012 | $7.4M | $7.8M | $5.3M | $21.8M |
| 2013 | $11.8M | $14.5M | $16.0M | $12.5M |
| 2014 | $12.0M | $18.4M | $14.6M | $30.4M |
| 2015 | $18.7M | $43.4M | $20.8M | $52.2M |
| 2016 | $42.5M | $33.3M | $31.9M | $39.0M |
| 2017 | $29.6M | $33.8M | $63.7M | $189.6M |
| 2018 | $30.9M | $35.2M | $25.6M | $60.2M |
| 2019 | $56.9M | $39.1M | $46.2M | $53.7M |
| 2020 | $25.4M | $55.2M | $65.3M | $121.7M |
| 2021 | $89.0M | $136.5M | $115.8M | $102.0M |
| 2022 | $117.3M | $152.4M | $209.0M | $181.5M |
| 2023 | $162.1M | $221.0M | $216.0M | $230.0M |
| 2024 | $195.9M | $231.4M | $290.1M | $298.0M |
Halozyme Jobs Nearby
Do you work at Halozyme?
Is Halozyme transparent about its revenue structure?
Halozyme Financial Information
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 136 |
| Date Founded | 1998 |
| Headquarters | San Diego, California |
| Number of Locations | 1 |
| Revenue | $1.0B |
| Net Income | $202,129,000 |
| Gross Proft | $855.9M (2024) |
| EBITDA | $646.3M (2024) |
| PE Ratio | 5.25 |
| Tax Rate | 0.2% |
| Market Capitalization | $2.3B |
| Total Assets | $1,841,511,000 |
| Ticker | HALO |
Halozyme Jobs You Might Like
Halozyme Financing
Halozyme received early financing of $30.0M on 2013-12-27.
| Series | Round Size | Date |
|---|---|---|
| Post Ipo Debt | $30M | 12/2013 |
| Post Ipo Debt | $20M | 01/2014 |
| Post Ipo Debt | $150M | 01/2016 |
| Post Ipo Equity | $30M | 02/2019 |
| Post Ipo Equity | $15M | 05/2020 |
Halozyme Investors
| Investors | Security Type |
|---|---|
| Oxford Finance LLC | Post Ipo Debt |
| Silicon Valley Bank | Post Ipo Debt |
| Oxford Finance LLC | Post Ipo Debt |
| Silicon Valley Bank | Post Ipo Debt |
| Athyrium Capital Management LP | Post Ipo Debt |
| PHARMAKON ADVISORS LP | Post Ipo Debt |
| ARGENX SE | Post Ipo Equity |
| Janssen Biotech Inc. | Post Ipo Equity |
Halozyme competitors
Halozyme's top competitor, Gilead Sciences, earned an annual revenue of $27.3B.
Halozyme's smallest competitor is Geron with revenue of $596.0K last year.
| Company Name | Average Salary | Revenue | Employee Size | Job Openings |
|---|---|---|---|---|
| Regeneron | $85,589 | $14.2B | 9,123 | 361 |
| Geron | $56,851 | $77.0M | 15 | 2 |
| Genentech | $97,473 | $166.9M | 13,638 | 395 |
| Amgen | $93,349 | $33.4B | 22,000 | 718 |
| Gilead Sciences | $99,828 | $28.8B | 11,800 | 528 |
| Cornerstone Pharmaceuticals | $45,352 | $890,000 | 30 | 28 |
| La Jolla Pharmaceutical | $69,611 | $75.7M | 169 | 4 |
| Vical | $75,394 | $12.4M | 213 | - |
| Protea Biosciences Group | $50,744 | $2.4M | 35 | - |
| DermTech | $44,207 | $15.3M | 114 | - |
Search for jobs
Related Company Revenues
Working At Related Companies
Related Company Jobs
Halozyme Highest Paying Jobs
Zippia gives an in-depth look into the details of Halozyme, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Halozyme. The employee data is based on information from people who have self-reported their past or current employments at Halozyme. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Halozyme. The data presented on this page does not represent the view of Halozyme and its employees or that of Zippia.
Halozyme may also be known as or be related to HALOZYME THERAPEUTICS INC., Halozyme, Halozyme Inc, Halozyme Therapeutics Inc, Halozyme Therapeutics, Inc. and Halozyme, Inc.